NASDAQ
Accelerate Diagnostics, Inc. (AXDX) has a free cash flow growth of -64.28% as of Friday, May 29, 2026. This represents a 450.04% decrease compared to its 12-month average of 18.36%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.